The most urgent risk isn't visual — it's data access.
Database read/write permissions do not isolate data by user. In theory, any authenticated account can access another's records.
Production X-Ray
We review code, infrastructure, data, and critical flows to identify risks, technical debt, and the right stabilization sequence.
Scope and investment are defined after an initial triage.
When it makes sense
Investigation scope
The depth of the analysis depends on the context. For larger products, we work with representative samples of the most critical flows.
See what you get
A simulated excerpt of the artifacts: the level of clarity, prioritization, and decision-making you receive at the end of the X-Ray.
Database read/write permissions do not isolate data by user. In theory, any authenticated account can access another's records.
Simulated example. The actual artifacts reflect your product's code, risks, and decisions.
The X-Ray can be executed by your own team, another vendor, or Origammi. When Origammi executes the fixes, that happens in the Stabilization Sprint.
Let's start
FAQ
Usually, read access to the repository, to the provider dashboard (Supabase, Firebase, Vercel, or similar), and time to talk with whoever built the product. We define the minimum necessary access during the initial triage.
We never ask for passwords or keys through a form. Access is granted via a collaborator invite, temporary access, or another proper mechanism — and revoked once the work is done.
For small products, yes. For larger or more complex ones, we work with representative samples of the most critical flows, to keep the X-Ray focused and fast.
An executive assessment, a risk map with issues classified by impact and urgency, recommended decisions (keep, protect, refactor, replace, or rebuild), and a prioritized stabilization plan — presented in a live readout.
No. The X-Ray can be executed by your own team, another vendor, or Origammi. When Origammi executes it, that happens as a separate Stabilization Sprint — a later decision, not an obligation.
We sign a confidentiality agreement when needed. Access is minimal, used only for the investigation, and revoked once the work is done.
We don't publish a fixed price, because scope varies a lot with product size and complexity. Scope and investment are defined after a free initial triage.